Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
Moderna
MRNA
|
$2.75B |
| 2 |
Coupang
CPNG
|
$1.09B |
| 3 |
Trade Desk
TTD
|
$793M |
| 4 |
BioNTech
BNTX
|
$736M |
| 5 |
Bilibili
BILI
|
$639M |
Top Sells
| 1 |
Tesla
TSLA
|
$7.41B |
| 2 |
Alphabet (Google) Class C
GOOG
|
$1.39B |
| 3 |
Meta Platforms (Facebook)
META
|
$880M |
| 4 |
Amazon
AMZN
|
$773M |
| 5 |
NIO
NIO
|
$619M |
Sector Composition
| 1 | Consumer Discretionary | 31.93% |
| 2 | Healthcare | 19.13% |
| 3 | Technology | 17.13% |
| 4 | Communication Services | 14.58% |
| 5 | Financials | 5.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Aptiv
APTV
$17.5B
| $21K | ﹤0.01% |
149
+2
| +1% | +$282 |
|
327
Quest Diagnostics
DGX
$20.5B
| $21K | ﹤0.01% |
160
+12
| +8% | +$1.58K |
|
328
Quaker Houghton
KWR
$2.51B
| $21K | ﹤0.01% |
86
+8
| +10% | +$1.95K |
|
329
Lightspeed Commerce
LSPD
$1.65B
| $21K | ﹤0.01% |
335
+23
| +7% | +$1.44K |
|
330
Rollins
ROL
$27.4B
| $21K | ﹤0.01% |
605
+22
| +4% | +$764 |
|
|
NVRO
331
DELISTED
NEVRO CORP.
NVRO
| $21K | ﹤0.01% |
154
+6
| +4% | +$818 |
|
332
Bandwidth Inc
BAND
$473M
| $20K | ﹤0.01% |
161
+11
| +7% | +$1.37K |
|
333
Shake Shack
SHAK
$4.03B
| $20K | ﹤0.01% |
174
+11
| +7% | +$1.26K |
|
|
SGEN
334
DELISTED
Seagen Inc. Common Stock
SGEN
| $20K | ﹤0.01% |
147
-3,243,632
| -100% | -$441M |
|
|
MNTV
335
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $20K | ﹤0.01% |
1,095
+67
| +7% | +$1.22K |
|
|
SAIL
336
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
| $20K | ﹤0.01% |
388
+23
| +6% | +$1.19K |
|
337
Home Depot
HD
$417B
| $19K | ﹤0.01% |
61
| – | – |
|
338
Outset Medical
OM
$249M
| $19K | ﹤0.01% |
23
+2
| +10% | +$1.65K |
|
339
Pacific Biosciences
PACB
$381M
| $19K | ﹤0.01% |
561
+53
| +10% | +$1.8K |
|
340
Progyny
PGNY
$1.94B
| $19K | ﹤0.01% |
436
+28
| +7% | +$1.22K |
|
341
Xencor
XNCR
$610M
| $19K | ﹤0.01% |
431
-18
| -4% | -$794 |
|
|
PFPT
342
DELISTED
Proofpoint, Inc.
PFPT
| $19K | ﹤0.01% |
154
+1
| +0.7% | +$123 |
|
343
Itron
ITRI
$5.51B
| $18K | ﹤0.01% |
204
+5
| +3% | +$441 |
|
344
nLIGHT
LASR
$1.44B
| $18K | ﹤0.01% |
542
+26
| +5% | +$863 |
|
345
Schrodinger
SDGR
$1.41B
| $18K | ﹤0.01% |
242
+17
| +8% | +$1.26K |
|
346
Silicon Laboratories
SLAB
$4.45B
| $18K | ﹤0.01% |
127
+8
| +7% | +$1.13K |
|
347
Viavi Solutions
VIAV
$2.6B
| $18K | ﹤0.01% |
1,142
+146
| +15% | +$2.3K |
|
348
Verint Systems
VRNT
$1.23B
| $18K | ﹤0.01% |
395
-329
| -45% | -$15K |
|
349
WD-40
WDFC
$2.95B
| $18K | ﹤0.01% |
58
-2
| -3% | -$621 |
|
350
ACM Research
ACMR
$1.76B
| $18K | ﹤0.01% |
660
+36
| +6% | +$982 |
|